Xiaoshan People's Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02234739
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Xiaoshan Hospital | Xiaoshan People's Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

voriconazole (vfend) (1 trial)

Drugs in Other Trials (2)

salvianolate (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aspergillosis (Phase 4)

Invasive Pulmonary Aspergillosis (Phase 4)

Pulmonary Aspergillosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3